NCT00747214View on ClinicalTrials.gov

A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

November 30, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

CRx-102

DRUG

Placebo

DRUG

DMARD Therapy

DMARD therapy can include methotrexate or other DMARD therapy

Sponsors

Lead Sponsor

Zalicus
All Listed Sponsors
lead

Zalicus

INDUSTRY

NCT00747214 - A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA | Biotech Hunter | Biotech Hunter